|
|
Active Org.- |
Originator Org.- |
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
MechanismAngiogenesis inhibitors [+1] |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Oncology Sciences Corporation
0 Patents (Medical) associated with Oncology Sciences Corporation
100 Deals associated with Oncology Sciences Corporation
100 Translational Medicine associated with Oncology Sciences Corporation